Colgate-Palmolive (NYSE:CL) Shares Bought by Catalina Capital Group LLC

Catalina Capital Group LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 15.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 2,990 shares of the company’s stock after purchasing an additional 397 shares during the period. Catalina Capital Group LLC’s holdings in Colgate-Palmolive were worth $272,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CL. Peak Financial Advisors LLC purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $1,315,000. Gordian Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 3rd quarter worth about $602,000. Carrera Capital Advisors increased its position in shares of Colgate-Palmolive by 23.1% in the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after acquiring an additional 7,353 shares in the last quarter. Fiduciary Alliance LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at about $4,066,000. Finally, Vontobel Holding Ltd. lifted its position in Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after acquiring an additional 550,750 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several research firms have issued reports on CL. Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday, January 6th. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research note on Monday. Wells Fargo & Company dropped their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Raymond James reaffirmed an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Stock Up 0.4 %

NYSE:CL opened at $87.05 on Tuesday. The stock has a market cap of $71.12 billion, a price-to-earnings ratio of 24.73, a PEG ratio of 3.61 and a beta of 0.44. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The stock has a 50-day moving average price of $91.35 and a two-hundred day moving average price of $97.15. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the company posted $0.87 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.